Press release
Annual General Meeting of Shareholders of DSM B.V.
Maastricht (Netherlands), May 29, 2024
DSM B.V. , a 98.5%-owned subsidiary of DSM-Firmenich AG, held its Annual General Meeting of Shareholders (AGM) today in Maastricht, the Netherlands. All resolutions on the agenda were approved by the shareholders.
The shareholders or shareholder representatives voted on 171,807,776 shares, or 98.73% of the issued share capital entitled to vote. The number of votes per share is 1 and the number of outstanding shares on May 29, 2024, the date of the meeting, was 174,018,034.
Agenda item 3
Financial statements for 2023
| For | Against | Abstain | Total | |
| Votes | 171,806,478
| 497 | 801 | 171,807,776 |
| % | 100.00 | 0.00 |
Agenda item 4
Release from liability of the members of the Managing Board
| For | Against | Abstain | Total | |
| Votes | 171,806,474
| 501 | 801 | 171,807,776 |
| % | 100.00 | 0.00 |
Agenda item 5
Release from liability of the members of the Supervisory Board
| For | Against | Abstain | Total | |
| Votes | 171,806,474
| 501 | 801 | 171,807,776 |
| % | 100.00 | 0.00 |
Agenda item 6
Reappointment of Thomas Leysen as member of the Supervisory Board
| For | Against | Abstain | Total | |
| Votes | 171,806,478
| 497 | 801 | 171,807,776 |
| % | 100.00 | 0.00 |
Agenda item 7
Appointment of the new External Auditor for 2025
| For | Against | Abstain | Total | |
| Votes | 171,806,478
| 497 | 801 | 171,807,776 |
| % | 100.00 | 0.00 |
Agenda item 8
Amendment of the Articles of Association of DSM B.V.
| For | Against | Abstain | Total | |
| Votes | 171,806,478
| 497 | 801 | 171,807,776 |
| % | 100.00 | 0.00 |
For more information:
dsm-firmenich media enquiries: media@dsm-firmenich.com
dsm-firmenich investor relations enquiries: investors@dsm-firmenich.com
About dsm-firmenich
As innovators in nutrition, health, and beauty, dsm-firmenich reinvents, manufactures, and combines vital nutrients, flavors, and fragrances for the world’s growing population to thrive. With our comprehensive range of solutions, with natural and renewable ingredients and renowned science and technology capabilities, we work to create what is essential for life, desirable for consumers, and more sustainable for the planet. dsm-firmenich is a Swiss-Dutch company, listed on the Euronext Amsterdam, with operations in almost 60 countries and revenues of more than €12 billion. With a diverse, worldwide team of nearly 30,000 employees, we bring progress to life™ every day, everywhere, for billions of people.
Forward-looking statements
This press release may contain forward-looking statements with respect to DSM’s future (financial) performance and position. Such statements are based on current expectations, estimates and projections of DSM and information currently available to the company. DSM cautions readers that such statements involve certain risks and uncertainties that are difficult to predict and therefore it should be understood that many factors can cause actual performance and position to differ materially from these statements. The information provided in this press release is provided as of the date of its issue. Furthermore, the information provided in this press release qualifies as inside information within the meaning of Article 7(1) of the EU Market Abuse Regulation. DSM does not assume any obligation to update any information or forward-looking statement provided in this press release unless required by law. The English language version of this press release prevails over other language versions.